KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Sales: 2019-2025

Historic Return on Sales for Castle Biosciences (CSTL) over the last 7 years, with Sep 2025 value amounting to -0.04%.

  • Castle Biosciences' Return on Sales fell 5.00% to -0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.04%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.05% for FY2024, which is 32.00% up from last year.
  • Latest data reveals that Castle Biosciences reported Return on Sales of -0.04% as of Q3 2025, which was down 30.40% from -0.03% recorded in Q2 2025.
  • Castle Biosciences' Return on Sales' 5-year high stood at 0.05% during Q4 2024, with a 5-year trough of -0.53% in Q2 2023.
  • Its 3-year average for Return on Sales is -0.16%, with a median of -0.04% in 2025.
  • In the last 5 years, Castle Biosciences' Return on Sales plummeted by 40bps in 2021 and then soared by 52bps in 2024.
  • Castle Biosciences' Return on Sales (Quarterly) stood at -0.33% in 2021, then decreased by 16bps to -0.49% in 2022, then grew by 23bps to -0.26% in 2023, then spiked by 32bps to 0.05% in 2024, then declined by 5bps to -0.04% in 2025.
  • Its Return on Sales was -0.04% in Q3 2025, compared to -0.03% in Q2 2025 and -0.01% in Q1 2025.